ACAD
Acadia Pharmaceuticals IncCompany with tickers: ACAD
Market Cap
$4.00B
Shares Outstanding
171,235,870
CIK
1070494
CUSIP
004225108
13F Activity (30d)
6 filings
4 filers
Website
Visit website
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-05-26 | JAMES K KIHARA | Officer | 5,401 | 2026-05-26 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-10 | James M Daly | Director | 30,000 | 2025-11-10 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-08-18 | Schneyer Mark C. | Officer | 22,000 | 2025-08-18 | Piper Sandler & Co Inc |
| 2025-06-04 | LAURA BREGE | Director | 14,446 | 2025-06-04 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-05-16 | Schneyer Mark C. | Officer | 2,000 | 2025-05-16 | Piper Sandler & Co Inc |
| 2025-05-16 | Kihara James | Officer | 4,000 | 2025-05-16 | Piper Sandler & Co |
| 2025-03-06 | GAROFALO ELIZABETH A. | Director | 4,919 | 2025-03-05 | MORGAN STANLEY SMITH BARNEY LLC EXECUTIVE SERVICES |
| 2023-12-15 | Kihara James | Officer | 2,000 | 2023-12-15 | Piper Sandler & Co. |
| 2023-09-15 | Kihara James | Officer | 2,000 | 2023-09-15 | Piper Sandler & Co |
| 2023-08-21 | Schneyer Mark C. | Officer | 10,000 | 2023-08-21 | Piper Sandler & Co. |
| 2023-07-14 | DAVIS STEPHEN | Officer, Director | 100,000 | 2023-07-14 | Piper Sandler & Co. |
| 2023-07-13 | DAVIS STEPHEN | Officer, Director | 71,602 | 2023-07-11 | Piper Sandler & Co. |
| 2023-06-15 | Kihara James | Officer | 2,000 | 2023-06-15 | Piper Sandler & Co. |
| 2023-06-12 | Brege Laura | Director | 4,500 | 2023-06-12 | Piper Sandler & Co. |
Showing 1–14 of 14 filings